Incidencia, morbimortalidad y tratamiento del síndrome coronario agudo durante el confinamiento por COVID-19

  1. Julio César Echarte Morales 1
  2. Carlos Minguito Carazo 1
  3. Pedro L. Cepas Guillén 2
  4. Víctor Vallejo García 3
  5. Dolores Poveda Pinedo 4
  6. Eduardo Martínez Gómez 5
  7. Enrique Sánchez Muñoz 1
  8. María López Benito 1
  9. Anthony Salazar Rodríguez 2
  10. Ignacio Cruz González 3
  11. Emilio Arbas Redondo 4
  12. Tomás Benito González 1
  13. Joan Guzmán Bofarull 2
  14. Daniel Tébar Márquez 4
  15. Ana Viana Tejedor 5
  16. Pedro Luis Sánchez Fernández 3
  17. Manel Sabaté Tenas 2
  18. Felipe Fernández Vázquez 1
  1. 1 Servicio de Cardiología, Complejo Asistencial Universitario de León, León, España
  2. 2 Servicio de Cardiología, Instituto Cardiovascular, Hospital Clínic, IDIBAPS, Universidad de Barcelona, Barcelona, España
  3. 3 Servicio de Cardiología, Hospital Clínico de Salamanca, Salamanca, España
  4. 4 Servicio de Cardiología, Hospital Universitario La Paz, Madrid, España
  5. 5 Servicio de Cardiología, Hospital Clínico San Carlos, Madrid, España
Journal:
REC: Interventional Cardiology

ISSN: 2604-7276 2604-7306

Year of publication: 2022

Volume: 4

Issue: 3

Pages: 186-192

Type: Article

DOI: 10.24875/RECIC.M22000267 DIALNET GOOGLE SCHOLAR lock_openDialnet editor

More publications in: REC: Interventional Cardiology

Abstract

Introduction and objectives: During the lockdown due to the pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a decrease in the number of admissions due to acute coronary syndrome (ACS) was observed. The objective of our study was to evaluate the impact lockdown had on the incidence, morbidity and mortality, and management of ACS. Methods: A retrospective and multicenter study was conducted including patients admitted due to ACS from February 14 through June 24, 2020. Patients with acute myocardial infarction and coronary arteries without significant lesions were excluded. The following groups were established based on the period of admission: a) 1 month before lockdown; b) during lockdown; and c) 1 month after lockdown. The differences in mortality seen among the 3 groups were evaluated, as well as the temporal differences reported between symptom onset and the first medical contact (FMC). Results: a total of 634 patients were included (group a, 205; group b, 303, and group c, 126). A 41% decrease in the number of admissions due to ACS was observed during the first month of lockdown compared to the previous month, as well as diagnostic delay during this same period (group a, 66 minutes (45-180), group b, 120 minutes (60-240), and group c, 120 minutes (60-240), P = .007). However, a higher mortality rate during confinement was not reported (RR, 1.26; 95%CI, 0.53-2.97; P = .60). Conclusions: During lockdown, a remarkable decrease in the number of admissions due to ACS was observed, and although there was an increase in the time elapsed from symptom onset to the FCM in this period in patients with STEMI, the mortality rate was similar in the 3 groups studied.

Bibliographic References

  • 1. World Health Organization. Pneumonia of Unknown Cause –China. WHO;2020. Disponible en: https://www.who.int/emergencies/disease-outbreak-news/item/2020-DON229. Consultado 20 Sep 2021.
  • 2. Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382:727-733.
  • 3. Morelli N, Rota E, Terracciano C, et al. The Baffling Case of Ischemic Stroke Disappearance from the Casualty Department in the COVID-19 Era. Eur Neurol. 2020;83:213-215.
  • 4. Babu N, Kohli P, Mishra C, et al. To evaluate the effect of COVID-19 pandemic and national lockdown on patient care at a tertiary-care ophthalmology institute. Indian J Ophthalmol. 2020;68:1540-1544.
  • 5. De Vincentiis L, Carr RA, Mariani MP, Ferrara G. Cancer diagnostic rates during the 2020 'lockdown', due to COVID-19 pandemic, compared with the 2018-2019:An audit study from cellular pathology. J Clin Pathol. 2021;74:187-189.
  • 6. De Rosa S, Spaccarotella C, Basso C, et al. Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era. Eur Heart J. 2020;41:2083-2088.
  • 7. Rodríguez-Leor O, Cid-Álvarez B, Ojeda S, et al. Impacto de la pandemia de COVID-19 sobre la actividad asistencial en cardiología intervencionista en España. REC Interv Cardiol. 2020;2:82-89.
  • 8. Romaguera R, Cruz-González I, Jurado-Román A, et al. Consideraciones sobre el abordaje invasivo de la cardiopatía isquémica y estructural durante el brote de coronavirus COVID-19. REC Interv Cardiol. 2020;2:112-117.
  • 9. Garcia S, Albaghdadi MS, Meraj PM, et al. Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States During COVID-19 Pandemic. J Am Coll Cardiol. 2020;75:2871-2872.
  • 10. Metzler B, Siostrzonek P, Binder RK, Bauer A, Reinstadler SJ. Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19:The pandemic response causes cardiac collateral damage. Eur Heart J. 2020;41:1852-1853.
  • 11. Pessoa-Amorim G, Camm CF, Gajendragadkar P, et al. Admission of patients with STEMI since the outbreak of the COVID-19 pandemic:A survey by the European Society of Cardiology. Eur Heart J Qual Care Clin Outcomes. 2020;6:210-216.
  • 12. Salinas P, Travieso-González A, Vergara-Uzcategui CE, Macaya F, Núñez-Gil IJ, Fernández-Ortiz A. Relación temporal entre ingresos por síndrome coronario agudo con tratamiento invasivo y confinamiento durante la pandemia de COVID-19. REC Interv Cardiol. 2020;2:307-309.
  • 13. Wong LE, Hawkins JE, Langness S, Murrell KL, Iris P, Sammann A. Where Are All the Patients?Addressing Covid-19 Fear to Encourage Sick Patients to Seek Emergency Care. NEJM Catal. 2020. Disponible en: https://catalyst.nejm.org/doi/full/10.1056/CAT.20.0193. Consultado 20 Sep 2021.
  • 14. Lai PH, Lancet EA, Weiden MD, et al. Characteristics Associated with Out-of-Hospital Cardiac Arrests and Resuscitations during the Novel Coronavirus Disease 2019 Pandemic in New York City. JAMA Cardiol. 2020;5:1154-1163.
  • 15. Marijon E, Karam N, Jost D, et al. Out-of-hospital cardiac arrest during the COVID-19 pandemic in Paris, France:a population-based, observational study. Lancet Public Health. 2020;5:e437-e443.
  • 16. Baldi E, Sechi GM, Mare C, et al. Out-of-Hospital Cardiac Arrest during the Covid-19 Outbreak in Italy. N Engl J Med. 2020;383:496-498.
  • 17. Tam CCF, Cheung KS, Lam S, et al. Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment-Elevation Myocardial Infarction Care in Hong Kong, China. Circ Cardiovasc Qual Outcomes. 2020;13:e006631.
  • 18. Gluckman TJ, Wilson MA, Chiu ST, et al. Case Rates, Treatment Approaches, and Outcomes in Acute Myocardial Infarction during the Coronavirus Disease 2019 Pandemic. JAMA Cardiol. 2020;5:1419-1424.
  • 19. Wu J, Mamas M, Rashid M, et al. Patient response, treatments, and mortality for acute myocardial infarction during the COVID-19 pandemic. Eur Heart J Qual Care Clin Outcomes. 2021;7:238-246.
  • 20. Franchini S, Spessot M, Landoni G, et al. Stranger months:How SARS-CoV-2, fear of contagion, and lockdown measures impacted attendance and clinical activity during February and March 2020 at an urban Emergency Department in Milan. Disaster Med Public Health Prep. 2020;15(5):e33-e42.
  • 21. Baldi E, Savastano S. Fear of contagion:One of the most devious enemies to fight during COVID-19 pandemic. Disaster Med Public Health Prep. 2021;15:e8-e9.
  • 22. Rodríguez-Leor O, Cid-Álvarez B, Pérez de Prado A, et al. Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience. Rev Esp Cardiol. 2020;73:994-1002.
  • 23. Mafham MM, Spata E, Goldacre R, et al. COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England. Lancet. 2020;39:381-389.
  • 24. Álvarez Gallego M, Gortázar de las Casas S, Pascual Migueláñez I, et al. SARS-CoV-2 pandemic on the activity and professionals of a General Surgery and Digestive Surgery Service in a tertiary hospital. Cir Esp. 2020;98:320-327.